We are live on ! Find out more
BNP Paribas Financial Markets

BNP Paribas Financial Markets Portfolio holdings

AUM $289B
1-Year Est. Return 60.46%
 

BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.

This Fund
S&P 500
This Quarter Est. Return
+0.08%
1 Year Est. Return
+60.46%
3 Year Est. Return
+148.24%
5 Year Est. Return
+163.86%
10 Year Est. Return
+570.16%
AUM
$56.3B
AUM Growth
+$6.14B
Cap. Flow
+$1.76B
Cap. Flow %
3.13%
Top 10 Hldgs %
15.08%
Holding
4,631
New
103
Increased
2,522
Reduced
1,306
Closed
116

Sector Composition

Rank Sector Weight
1 Technology 8.31%
2 Financials 6.96%
3 Consumer Discretionary 5.46%
4 Healthcare 4.97%
5 Industrials 4.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ZVO
4176
DELISTED
Zovio Inc. Common Stock
ZVO
$3.53K ﹤0.01%
1,790
ASR icon
4177
Grupo Aeroportuario del Sureste
ASR
$8.03B
$3.51K ﹤0.01%
23
-100
-81% -$15.2K
VERI icon
4178
Veritone
VERI
$140M
$3.49K ﹤0.01%
978
BAS
4179
DELISTED
Basis Energy Services, Inc.
BAS
$3.48K ﹤0.01%
2,416
-243
-9% -$407
EVFM
4180
DELISTED
Evofem Biosciences, Inc. Common Stock
EVFM
$3.47K ﹤0.01%
46
+41
+820% +$3.15K
AVTX icon
4181
Avalo Therapeutics
AVTX
$1.05B
0
ORGO icon
4182
Organogenesis Holdings
ORGO
$232M
$3.42K ﹤0.01%
521
+494
+1,830% +$2.75K
KA
4183
DELISTED
Kineta, Inc. Common Stock
KA
$3.36K ﹤0.01%
28
FSK icon
4184
FS KKR Capital
FSK
$3.5B
$3.33K ﹤0.01%
143
CIX icon
4185
Comp X International
CIX
$388M
$3.31K ﹤0.01%
231
+8
+4% +$122
TPST icon
4186
Tempest Therapeutics
TPST
$18.9M
$3.3K ﹤0.01%
+2
New +$3.23K
HSDT icon
4187
Solana Company
HSDT
$105M
0
COGT icon
4188
Cogent Biosciences
COGT
$6.56B
$3.25K ﹤0.01%
565
IVAC
4189
DELISTED
Intevac Inc
IVAC
$3.23K ﹤0.01%
617
ATCO
4190
DELISTED
Atlas Corp.
ATCO
$3.19K ﹤0.01%
300
-1,100
-79% -$11.5K
CHRA
4191
DELISTED
Charah Solutions, Inc Common Stock
CHRA
$3.12K ﹤0.01%
147
+7
+5% +$276
INSE icon
4192
Inspired Entertainment
INSE
$165M
$3.1K ﹤0.01%
431
+368
+584% +$2.8K
GCVRZ
4193
DELISTED
Sanofi Contingent Value Rights
GCVRZ
$3.06K ﹤0.01%
5,455
BBGI icon
4194
Beasley Broadcasting Group
BBGI
$46.6M
$2.99K ﹤0.01%
48
TECK icon
4195
Teck Resources
TECK
$31.2B
$2.97K ﹤0.01%
+183
New +$3.46K
AINC
4196
DELISTED
Ashford Inc.
AINC
$2.96K ﹤0.01%
122
CRIS icon
4197
Curis
CRIS
$3.34M
$2.95K ﹤0.01%
3
NH
4198
DELISTED
NantHealth, Inc
NH
$2.92K ﹤0.01%
271
CIH
4199
DELISTED
China Index Holdings Limited American Depository Shares
CIH
$2.9K ﹤0.01%
744
TKC icon
4200
Turkcell
TKC
$4.73B
$2.89K ﹤0.01%
500

Similar funds

BNP Paribas Financial Markets's Q3 2019 Portfolio in Review

As of Q3 2019, BNP Paribas Financial Markets held 4,631 positions worth $56.3B, up 12% from $50.2B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

BNP Paribas Financial Markets deployed $1.76B of net new capital in Q3 2019, opening 103 new positions and adding to 2,522 existing holdings. Its largest new stake was VanEck Pharmaceutical ETF: 400,000 shares worth $22.8M.

By sector, the portfolio is most concentrated in Technology at 8.3% of assets, down from 8.5% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Apple, an estimated $235M trimmed.

  • BNP Paribas Financial Markets's largest Q3 2019 buy was VanEck Pharmaceutical ETF: 400,000 shares worth $22.8M.
  • BNP Paribas Financial Markets added most to Visa in Q3 2019, an estimated $344M increase.
  • BNP Paribas Financial Markets's biggest Q3 2019 reduction was Apple, cutting an estimated $235M.
  • BNP Paribas Financial Markets fully exited Anadarko Petroleum in Q3 2019, selling an estimated $122M.
  • BNP Paribas Financial Markets's ten largest holdings make up 15% of its $56.3B portfolio in Q3 2019.
  • BNP Paribas Financial Markets opened 103 new positions and closed 116 in Q3 2019.
  • BNP Paribas Financial Markets's portfolio value rose 12% quarter-over-quarter to $56.3B.

Based on BNP Paribas Financial Markets's 13F filing for Q3 2019, filed 7 Nov 2019.